These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 20153515)
21. Scott syndrome: an inherited defect of the procoagulant activity of platelets. Platelets; 1997 Apr; 8(2):117-24. PubMed ID: 16793639 [TBL] [Abstract][Full Text] [Related]
22. Scott syndrome: an inherited defect of the procoagulant activity of platelets. Satta N; Toti F; Fressinaud E; Meyer D; Freyssinet JM Platelets; 1997; 8(2-3):117-24. PubMed ID: 20297932 [TBL] [Abstract][Full Text] [Related]
23. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets. Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312 [TBL] [Abstract][Full Text] [Related]
24. Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization and microparticles formation. Zhu J; Xie R; Piao X; Hou Y; Zhao C; Qiao G; Yang B; Shi J; Lu Y Amino Acids; 2012 Sep; 43(3):1243-50. PubMed ID: 22160264 [TBL] [Abstract][Full Text] [Related]
25. Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans. Lubsczyk B; Kollars M; Hron G; Kyrle PA; Weltermann A; Gartner V Eur J Clin Invest; 2010 Jun; 40(6):477-82. PubMed ID: 20456486 [TBL] [Abstract][Full Text] [Related]
26. Procoagulant activity induced by transcatheter closure of atrial septal defects is associated with exposure of phosphatidylserine on microparticles, platelets and red blood cells. Ding W; Kou J; Meng H; Kou Y; He Z; Cao M; Wang L; Bi Y; Thatte HS; Shi J Thromb Res; 2015 Aug; 136(2):354-60. PubMed ID: 26099643 [TBL] [Abstract][Full Text] [Related]
27. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets. Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961 [TBL] [Abstract][Full Text] [Related]
28. Role of cAMP-dependent protein kinase in the regulation of platelet procoagulant activity. Yan R; Wang Z; Yuan Y; Cheng H; Dai K Arch Biochem Biophys; 2009 May; 485(1):41-8. PubMed ID: 19268649 [TBL] [Abstract][Full Text] [Related]
29. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines. Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359 [TBL] [Abstract][Full Text] [Related]
31. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Montoro-García S; Shantsila E; Marín F; Blann A; Lip GY Basic Res Cardiol; 2011 Nov; 106(6):911-23. PubMed ID: 21691898 [TBL] [Abstract][Full Text] [Related]
32. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Lacroix R; Dignat-George F Thromb Res; 2012 May; 129 Suppl 2():S27-9. PubMed ID: 22424856 [TBL] [Abstract][Full Text] [Related]
33. Contact activation of the plasma coagulation cascade. I. Procoagulant surface chemistry and energy. Vogler EA; Graper JC; Harper GR; Sugg HW; Lander LM; Brittain WJ J Biomed Mater Res; 1995 Aug; 29(8):1005-16. PubMed ID: 7593031 [TBL] [Abstract][Full Text] [Related]
34. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967 [TBL] [Abstract][Full Text] [Related]
35. Initiation of coagulation by tissue factor carriers in blood. Engelmann B Blood Cells Mol Dis; 2006; 36(2):188-90. PubMed ID: 16473535 [TBL] [Abstract][Full Text] [Related]